Harvey M. Golomb to Cost-Benefit Analysis
This is a "connection" page, showing publications Harvey M. Golomb has written about Cost-Benefit Analysis.
Connection Strength
0.004
-
Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Apr 19; 81(8):594-602.
Score: 0.004
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.